Russian study tracks Real-Life MG care without new drugs

NCT ID NCT07247279

Recruiting now Knowledge-focused Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Jan 04, 2026 · Last updated May 15, 2026 · Updated 22 times

Summary

This study looks at how doctors in Russia currently treat a rare muscle-weakening disease called generalized myasthenia gravis (gMG). Researchers will collect medical records and follow about 450 adults with the AChR-antibody form of the disease to see which treatments are used and how patients do over time. No experimental drugs are given—this is purely an observation of real-world care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RARE DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Research Site
RECRUITING

Kazan', Russia
Research Site
RECRUITING

Moscow, Russia
Research Site
RECRUITING

Novosibirsk, Russia
Research Site
RECRUITING

Rostov-on-Don, Russia
Research Site
NOT_YET_RECRUITING

Saint Petersburg, Russia
Research Site
RECRUITING

Samara, Russia

Conditions

Explore the condition pages connected to this study.

GENERALIZED MYASTHENIA GRAVIS (GMG) RARE DISEASES